These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Comparison of bone scintigraphy and 18F-FDG PET-CT in a prostate cancer patient with osteolytic bone metastases. Ozcan Kara P; Kara T; Kara Gedik G; Sari O; Sahin O Rev Esp Med Nucl; 2011; 30(2):94-6. PubMed ID: 21342722 [TBL] [Abstract][Full Text] [Related]
26. Low Accuracy of Computed Tomography and Positron Emission Tomography to Detect Lung and Lymph Node Metastases of Colorectal Cancer. Guerrera F; Renaud S; Schaeffer M; Nigra V; Solidoro P; Santelmo N; Filosso PL; Falcoz PE; Ruffini E; Oliaro A; Massard G Ann Thorac Surg; 2017 Oct; 104(4):1194-1199. PubMed ID: 28760464 [TBL] [Abstract][Full Text] [Related]
27. Subcutaneous metastases of colorectal cancer detected with PET/CT. Karyagar S; Karyagar SS; Kece C; Ozdil B Clin Nucl Med; 2010 Apr; 35(4):267-8. PubMed ID: 20305419 [TBL] [Abstract][Full Text] [Related]
28. Incidental, early diagnosis of urinoma by F-18 FDG PET/CT. Sanchez MJ; Caride VJ Clin Nucl Med; 2005 Feb; 30(2):102-4. PubMed ID: 15647676 [No Abstract] [Full Text] [Related]
29. Impact of Fluorodeoxyglucose PET/Computed Tomography on the Management of Patients with Colorectal Cancer. Laurens ST; Oyen WJ PET Clin; 2015 Jul; 10(3):345-60. PubMed ID: 26099671 [TBL] [Abstract][Full Text] [Related]
30. Novel strategy for a cocktail 18F-fluoride and 18F-FDG PET/CT scan for evaluation of malignancy: results of the pilot-phase study. Iagaru A; Mittra E; Yaghoubi SS; Dick DW; Quon A; Goris ML; Gambhir SS J Nucl Med; 2009 Apr; 50(4):501-5. PubMed ID: 19289439 [TBL] [Abstract][Full Text] [Related]
31. Characterizing and predicting pathologic spine fractures in myeloma patients with FDG PET/CT and MR imaging. Mulligan M; Chirindel A; Karchevsky M Cancer Invest; 2011 Jun; 29(5):370-6. PubMed ID: 21599514 [TBL] [Abstract][Full Text] [Related]
32. A comparative study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and (99m)Tc-MDP whole-body bone scanning for imaging osteolytic bone metastases. Zhang L; Chen L; Xie Q; Zhang Y; Cheng L; Li H; Wang J BMC Med Imaging; 2015 Mar; 15():7. PubMed ID: 25885599 [TBL] [Abstract][Full Text] [Related]
33. Clinical value of (18)F-FDG PET/CT in postoperative monitoring for patients with colorectal carcinoma. Han A; Xue J; Zhu D; Zheng J; Yue J; Yu J Cancer Epidemiol; 2011 Oct; 35(5):497-500. PubMed ID: 21296635 [TBL] [Abstract][Full Text] [Related]
34. FDG-PET and CT patterns of bone metastases and their relationship to previously administered anti-cancer therapy. Israel O; Goldberg A; Nachtigal A; Militianu D; Bar-Shalom R; Keidar Z; Fogelman I Eur J Nucl Med Mol Imaging; 2006 Nov; 33(11):1280-4. PubMed ID: 16791597 [TBL] [Abstract][Full Text] [Related]
35. 18F-FDG PET/CT is a prognostic biomarker in patients affected by bone metastases from breast cancer in comparison with 18F-NaF PET/CT. Piccardo A; Puntoni M; Morbelli S; Massollo M; Bongioanni F; Paparo F; Altrinetti V; Gonella R; Gennari A; Iacozzi M; Sambuceti G; DeCensi A Nuklearmedizin; 2015; 54(4):163-72. PubMed ID: 26165806 [TBL] [Abstract][Full Text] [Related]
37. Significance of hormone receptor status in comparison of 18F -FDG-PET/CT and 99mTc-MDP bone scintigraphy for evaluating bone metastases in patients with breast cancer: single center experience. Teke F; Teke M; Inal A; Kaplan MA; Kucukoner M; Aksu R; Urakci Z; Tasdemir B; Isikdogan A Asian Pac J Cancer Prev; 2015; 16(1):387-91. PubMed ID: 25640386 [TBL] [Abstract][Full Text] [Related]
38. Fusion of metabolic function and morphology: sequential [18F]fluorodeoxyglucose positron-emission tomography/computed tomography studies yield new insights into the natural history of bone metastases in breast cancer. Du Y; Cullum I; Illidge TM; Ell PJ J Clin Oncol; 2007 Aug; 25(23):3440-7. PubMed ID: 17592153 [TBL] [Abstract][Full Text] [Related]
39. Utility of F-18 FDG PET/CT on the evaluation of primary bone lymphoma. Wang LJ; Wu HB; Wang M; Han YJ; Li HS; Zhou WL; Wang QS Eur J Radiol; 2015 Nov; 84(11):2275-9. PubMed ID: 26388466 [TBL] [Abstract][Full Text] [Related]
40. The clinical value of 18F-FDG PET/CT in the evaluation of bone metastases undetermined origin. Hu J; Zhang X; Li B; Zhang M; Wang C; Chen G Clin Imaging; 2013; 37(5):922-4. PubMed ID: 23849830 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]